outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0204967348,1.0204967348,1.0204967348,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3358,1450,0.2224510515,0.0597386527,0.8283492864,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,550,1423,1.0815785795,0.3626590398,3.2256530111,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,2.6768287E-6,1.3721675E-6,5.2219659E-6,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2048451361,0.0719357705,0.5833193903,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,550,7226,0.708197361,0.2896508527,1.7315450562,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0353455939,0.7529914302,1.423575961,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3358,1450,0.2438178757,0.0617151674,0.9632503482,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,550,1423,0.8796591313,0.1647386889,4.6971369773,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,7.7010469E-7,3.6679709E-7,1.6168646E-6,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2530923209,0.0835928992,0.766281867,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,550,7226,0.5384447023,0.1275091391,2.2737405305,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.1760181459,0.7596975386,1.8204859292,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3358,1450,0.2747903064,0.0681547266,1.1079160067,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,550,1423,1.0039713891,0.1709112513,5.8975552666,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,6.9055921E-7,3.2735437E-7,1.4567456E-6,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2386294823,0.079102662,0.719875013,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,550,7226,0.5219745806,0.1253686198,2.1732508754,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,717,350,1.0129264387,0.7463358256,1.3747430245,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3358,1450,0.2328806552,0.0593639536,0.91357459,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,550,1423,0.8075320287,0.1641223881,3.9733030027,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,717,1493,7.4866362E-7,3.5871646E-7,1.5625077E-6,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2511972907,0.0830393261,0.7598818758,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,550,7226,0.4874544741,0.1282931128,1.8521014827,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,717,350,1.033551518,0.7533476457,1.4179758131,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3358,1450,0.2440270348,0.061773265,0.9639962158,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,550,1423,0.8527303489,0.1629660629,4.4619661004,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,7.6650908E-7,3.6531501E-7,1.6083001E-6,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2538559727,0.083832295,0.7687115674,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,550,7226,0.5431346062,0.1282926501,2.2993928347,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,717,350,1.1544238388,0.7219228725,1.8460343209,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3358,1450,0.2641662263,0.0661719726,1.0545823615,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,550,1423,0.9139144811,0.1655453501,5.0453829008,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,6.5953136E-7,3.1497299E-7,1.3810124E-6,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2366476464,0.078484792,0.7135408932,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,550,7226,0.4827203794,0.1255068923,1.8566228541,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.1483362093,0.7297369038,1.8070568211,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3358,1450,0.2759610967,0.0695578326,1.0948375478,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,550,1423,1.0477019978,0.1796694127,6.1094398865,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,2.3653588E-7,1.1098946E-7,5.0409491E-7,0,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3358,5227,0.2282668575,0.0777753769,0.6699518581,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,550,7226,0.50609018,0.1232670531,2.0778242351,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,718,350,0.9313393766,0.1985527596,4.3685770788,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,0.7993132984,0.3290604246,1.9415940087,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,552,1438,1.0235642913,0.6399120795,1.6372309448,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,1.2009241097,0.5307914012,2.7171101754,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9880970118,0.6006091363,1.6255758457,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,1.9772012252,1.3397273735,2.9180001559,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,1.1849011623,0.1729906818,8.1159906989,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,0.852826281,0.3367350783,2.1598957535,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,552,1438,0.9928830211,0.5747202112,1.7152984605,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,1.7170787934,0.4080394746,7.2256724315,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0718617279,0.6052201774,1.8982968623,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,2.1197646725,1.3235228808,3.3950317987,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,1.2598843409,0.1901794895,8.3463708749,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,0.8934454537,0.3509152504,2.2747508915,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,1.0713782341,0.625759335,1.834333515,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,1.6026335168,0.4180127587,6.1443918532,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0400648342,0.5856243383,1.8471480584,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,2.1226025261,1.3274144352,3.3941483267,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,1.1288512039,0.1562835326,8.1538023815,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3363,1455,0.8081803094,0.3199093993,2.0416887215,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,552,1438,0.8724730289,0.505291829,1.506474363,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1493,1.6050673105,0.3519660155,7.3195733616,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0715308327,0.6056248452,1.8958573686,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,552,7253,1.8500668032,1.1522319105,2.9705366993,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,1.1590934122,0.1699204304,7.9066274418,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3363,1455,0.8338714715,0.3292696182,2.1117697855,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,552,1438,1.1557196451,0.6327271561,2.1110013776,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,1.7181555606,0.4101486937,7.1975324456,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0694892996,0.6034919579,1.8953150029,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.9771735361,1.2168959996,3.2124480591,1,1
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,1.2083354957,0.1724712811,8.4656103974,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3363,1455,0.8338402376,0.3288097397,2.1145649227,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,552,1438,1.1476642842,0.6228488818,2.1146916173,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,1.4914834243,0.3571942268,6.2277680826,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0366289117,0.5835934099,1.841349615,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.7127967612,1.054994926,2.7807458337,1,1
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,1.03837209,0.1963323785,5.4917920608,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,0.8316309384,0.3237984082,2.1359277881,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,1.0689393691,0.6075670324,1.8806671758,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,1.4468963357,0.5032083593,4.1603223947,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.116732463,0.6165135051,2.0228127747,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,2.3442742163,1.4763512978,3.7224349037,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,708,345,0.374320405,0.1361505178,1.0291240008,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3330,1424,0.6170105683,0.3695616901,1.0301447674,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,507,1287,1.0038141429,0.6792582146,1.4834459296,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,708,1484,0.2439175238,0.1173019518,0.5072017773,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.471825583,0.3397080915,0.6553255171,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,507,7044,0.6962041108,0.5046613075,0.9604464552,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,708,345,0.3870100285,0.1038209712,1.4426445873,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3330,1424,0.8473246143,0.476187258,1.5077240935,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,507,1287,1.2304759559,0.7516809166,2.0142470622,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,708,1484,0.2040021355,0.0674134774,0.6173375552,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.6038656193,0.4008500633,0.9097009569,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,507,7044,0.8825841774,0.5759943372,1.3523654313,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,708,345,0.3689255702,0.0980066928,1.3887426708,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3330,1424,0.8015313448,0.4505010175,1.4260844521,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,507,1287,1.1571757408,0.7263722874,1.8434840072,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,708,1484,0.2158921967,0.0714513248,0.6523243718,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.6185210941,0.4100947409,0.9328779566,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,507,7044,0.8976235645,0.581585544,1.3853990559,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,708,345,0.3810061364,0.1018371006,1.425469452,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3330,1424,0.8122904712,0.4554337989,1.4487633794,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,507,1287,1.124582094,0.6824618184,1.8531218186,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,708,1484,0.1993692063,0.0656811321,0.6051674072,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.5994160923,0.3976723621,0.9035067205,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,507,7044,0.7991312595,0.5187310489,1.2311018807,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,708,345,0.3859985181,0.1035675082,1.4386254776,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3330,1424,0.8477104925,0.4763951712,1.5084390493,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,507,1287,1.1661048349,0.715323956,1.9009575655,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,708,1484,0.2041209273,0.0674556769,0.6176700748,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.6067817181,0.402783575,0.9140989758,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,507,7044,0.8925999134,0.5824074823,1.3680020082,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,708,345,0.3613717104,0.0955047084,1.3673620421,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3330,1424,0.7768313652,0.435804895,1.3847182003,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,507,1287,1.0205656957,0.637468816,1.6338906516,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,708,1484,0.2077207529,0.068439471,0.6304536041,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.6135709179,0.4064907548,0.9261447322,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,507,7044,0.8170837983,0.5262237658,1.2687111013,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,708,345,0.3674378613,0.0948620622,1.4232305184,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3330,1424,0.8060013151,0.4517777375,1.4379595671,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,507,1287,1.1530678686,0.7195401868,1.8477988219,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,708,1484,0.2135228191,0.0716130255,0.6366438784,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3330,5193,0.6154280421,0.4060854441,0.9326896112,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,507,7044,0.9232430157,0.5986691236,1.4237875856,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,712,348,1.2484022045,0.1399306508,11.137717546,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3348,1445,1.8638381337,0.5583302666,6.2219313483,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,521,1360,1.1229739708,0.6779142698,1.8602212631,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1491,0.3671043198,0.1272572141,1.0590015075,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7058962417,0.421300947,1.182740052,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,521,7133,0.7460196009,0.4961844037,1.1216500171,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,712,348,0.5486206058,0.0574594755,5.2382059976,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3348,1445,2.3637857373,0.6805590518,8.210136942,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,521,1360,1.3024047887,0.6986066105,2.4280592369,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1491,0.19609336,0.0594092514,0.6472494588,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7427872313,0.4065399718,1.3571429853,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,521,7133,0.9142120933,0.5327137095,1.568917294,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,348,0.5312874836,0.0554786951,5.0878339836,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3348,1445,2.2746165615,0.6539174347,7.9121311464,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,521,1360,1.2450776632,0.6912867057,2.2425114998,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1491,0.2067489796,0.0624756687,0.6841886045,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7571937767,0.4134824698,1.3866184358,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,521,7133,0.9235705595,0.5335431784,1.5987133055,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,712,348,0.5450284033,0.0570014558,5.2113749798,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3348,1445,2.3362885655,0.6723447252,8.118222776,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,521,1360,1.2733121046,0.6636947787,2.4428755019,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,712,1491,0.1940322523,0.0586250101,0.6421920419,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7416075874,0.4061816998,1.3540290317,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,521,7133,0.8902507556,0.5038911039,1.57285255,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,712,348,0.5484191479,0.0574441793,5.2357534769,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3348,1445,2.3674067566,0.6816002281,8.2227301579,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,521,1360,1.2526095694,0.6772241585,2.3168558204,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1491,0.1961102308,0.0594152867,0.6472950772,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7454981371,0.4080542535,1.3619940675,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,521,7133,0.9279043258,0.5388769499,1.5977793038,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,712,348,0.5280523394,0.0550415421,5.0659785773,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3348,1445,2.2641209938,0.6508701301,7.8759857571,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,521,1360,1.1818508631,0.640688122,2.1801113752,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1491,0.2039327694,0.0613674976,0.6776970882,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7575352852,0.414016501,1.3860793155,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,521,7133,0.9139726298,0.5082332434,1.6436271709,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,348,0.4873791964,0.0503264322,4.7199547193,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3348,1445,2.1572732056,0.6212965293,7.4905097067,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,521,1360,1.1610032416,0.6341951114,2.125416142,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1491,0.2124303426,0.0637692155,0.7076557249,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3348,5216,0.7766050372,0.4176369155,1.4441141608,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,521,7133,0.9836621689,0.574958589,1.6828886133,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0370222691,0.868487122,1.2382626747,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3350,1445,1.2502601203,0.3646489112,4.2867270963,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,532,1388,0.8091256209,0.4708319713,1.3904838886,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,3.8941921E-6,2.3869891E-6,6.3530799E-6,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.415706702,0.2374048471,0.7279213724,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,532,7167,0.7889130161,0.4992060375,1.2467472349,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0761308383,0.749986633,1.5441042948,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3350,1445,1.7367826747,0.4695360549,6.4242437348,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,532,1388,0.8741763835,0.4666528153,1.6375864979,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,1.3606311E-6,7.7235192E-7,2.3969862E-6,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.5186539208,0.2568603558,1.0472690063,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,532,7167,0.9364046108,0.5179941032,1.6927868284,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.1520011009,0.7927292883,1.6740980256,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3350,1445,1.8794131074,0.5058119886,6.9832145298,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,532,1388,0.9905147871,0.5273751425,1.860382609,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,1.2231767E-6,6.8811103E-7,2.1743022E-6,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.4988069625,0.2463929008,1.0098033874,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,532,7167,0.9339591191,0.5124673554,1.7021174658,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,717,350,1.0444738771,0.7099433759,1.5366375924,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3350,1445,1.6765353335,0.4524204856,6.2127397279,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,532,1388,0.8163525558,0.4330015557,1.5390972311,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,717,1493,1.3094256E-6,7.3519921E-7,2.3321507E-6,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.5170655029,0.2563001828,1.0431390696,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,532,7167,0.8641986394,0.4748633441,1.5727457124,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,717,350,1.0775508449,0.7526854071,1.5426309749,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3350,1445,1.740725458,0.4706262534,6.4384957232,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,532,1388,0.8610127138,0.4631962111,1.600494295,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,1.3543329E-6,7.696498E-7,2.3831848E-6,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.5195889673,0.2573604551,1.0490061295,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,532,7167,0.9517195831,0.5239065353,1.7288773928,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,717,350,1.1075110347,0.7539546831,1.626862621,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3350,1445,1.8390371136,0.4942044848,6.8434375021,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,532,1388,0.9298363588,0.4932853164,1.7527293543,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,1.1512431E-6,6.4955064E-7,2.0404271E-6,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.4964845159,0.2454244179,1.0043698042,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,532,7167,0.8789891869,0.4780076154,1.6163382463,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.1500807874,0.7398252924,1.7878353594,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3350,1445,1.7912392117,0.4918761471,6.5230605965,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,532,1388,0.9567955836,0.4998434916,1.8314888646,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,4.1828014E-7,2.2864444E-7,7.6519804E-7,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3350,5224,0.5120356031,0.2464142187,1.0639826721,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,532,7167,1.0537228002,0.5753938976,1.9296898081,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0454691981,0.8614826124,1.2687497443,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3360,1453,1.3032776724,0.1577401123,10.767918615,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,546,1421,0.6144014834,0.2825944368,1.3357983511,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,0.0000243526,3.4201173E-6,0.0001733999,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5715327557,0.2201433516,1.4838044778,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,546,7227,0.9091076375,0.4647077782,1.7784869017,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,717,350,1.0854108213,0.7215888636,1.6326702232,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3360,1453,1.5526612203,0.1830299566,13.171378664,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,546,1421,0.6620461429,0.2747885305,1.5950632823,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,717,1493,9.8891282E-6,1.3565964E-6,0.0000720884,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5853643954,0.2135396157,1.6046271991,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,546,7227,0.9894721342,0.4373731291,2.2384893797,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.2025589732,0.7835338665,1.8456739981,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3360,1453,1.7372661289,0.2036971861,14.816569928,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,546,1421,0.7862464752,0.3193477147,1.9357693551,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,8.4060435E-6,1.1498012E-6,0.0000614555,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5490480101,0.1990888977,1.5141663895,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,546,7227,0.9743635591,0.4279907182,2.2182358283,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,717,350,1.0416509603,0.6692518077,1.621268274,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3360,1453,1.4834038165,0.1753191501,12.551320732,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,546,1421,0.6103238939,0.2465434112,1.5108708593,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,717,1493,9.4110599E-6,1.2843396E-6,0.00006896,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5830475051,0.212863025,1.5970100641,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,546,7227,0.8977764334,0.3904126836,2.064488574,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,717,350,1.0956405075,0.7251089819,1.6555140698,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3360,1453,1.5430269902,0.181903103,13.089014169,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,546,1421,0.6981988184,0.2823664115,1.7264149354,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,8.4818021E-6,1.1625679E-6,0.0000618811,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5822782367,0.2123201262,1.5968714366,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,546,7227,0.9395818629,0.4076120472,2.1658193942,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,717,350,1.1518378731,0.7269462858,1.825073615,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3360,1453,1.6582994942,0.1945588253,14.134322659,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,546,1421,0.7984371435,0.3038993145,2.0977404083,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,717,1493,6.5764572E-6,9.0126397E-7,0.0000479879,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.542303896,0.1965854519,1.4960085438,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,546,7227,0.8449843523,0.3606706515,1.9796414059,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,717,350,1.2175070207,0.7349209942,2.0169832638,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3360,1453,1.6857653333,0.1999608323,14.211807015,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,546,1421,0.7838971284,0.3122176779,1.9681611624,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,717,1493,1.6676704E-6,2.2625155E-7,0.0000122922,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3360,5232,0.5413732413,0.1966175988,1.4906345524,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,546,7227,0.9810532221,0.4247497571,2.2659587405,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,718,350,0.9333074331,0.3157948919,2.7583180951,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,1.034309065,0.7129049583,1.5006141135,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,552,1438,0.8498538833,0.6637891163,1.0880739157,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,0.6505691513,0.3760311265,1.1255457085,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9726394584,0.8056331017,1.1742659458,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,1.7577196232,1.4312161774,2.1587083226,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,0.7991730053,0.2064901986,3.0930160202,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,0.9925752792,0.6629551348,1.4860819883,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,552,1438,0.9022566053,0.6672667335,1.2200023483,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,0.579348249,0.2195158466,1.5290212474,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9133313445,0.72623261,1.1486321786,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,1.8741851494,1.4382344067,2.4422791987,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,0.8632127103,0.2244823725,3.3193527628,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,1.0836036626,0.7195333363,1.6318867222,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,1.0236644576,0.7629710784,1.373432036,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,0.5250743883,0.1972445989,1.3977726884,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.8691459022,0.6896597469,1.0953439035,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,1.8535130599,1.428230724,2.4054311433,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,0.8237517287,0.2116957033,3.2053882049,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3363,1455,1.0229620123,0.6817222906,1.5350110935,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,552,1438,0.9605629514,0.7040747614,1.3104875139,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1493,0.6028462948,0.2272716538,1.5990716358,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9145771973,0.7267082051,1.1510141814,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,552,7253,2.0155541184,1.5300351844,2.6551405129,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,0.7907050382,0.2041983672,3.0617994941,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3363,1455,0.9782018621,0.653894365,1.463353921,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,552,1438,1.0066362697,0.7357012217,1.3773479635,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,0.579959871,0.219766653,1.5305026825,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9069757013,0.7206011266,1.141553756,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.7239530084,1.306270806,2.2751897703,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,0.8527684387,0.2201748098,3.3028937811,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3363,1455,1.0840844497,0.7188277275,1.6349384548,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,552,1438,1.1542321103,0.8528984609,1.5620285714,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,0.5439653927,0.2033879111,1.4548472762,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.8687901428,0.6884992655,1.0962921096,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.7917252221,1.3490851425,2.3795972325,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,0.784829355,0.2054931058,2.9974587905,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,1.0125645345,0.672526535,1.5245300864,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,0.9890561134,0.7273089673,1.3450019723,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,0.5323739261,0.1968165519,1.4400313107,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.8900844506,0.7013299882,1.129639888,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,1.9437722881,1.4909953359,2.5340459604,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,718,350,0.8069759888,0.2148432754,3.0310943889,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,1.1538363127,0.5621819783,2.368162424,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,552,1438,0.8529358171,0.5074922303,1.4335185148,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,2.0805270049,0.8015520739,5.4002637621,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0590356046,0.7091088259,1.5816421553,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,1.218396548,0.7827162897,1.8965877773,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,0.4818059424,0.1009277359,2.3000314425,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3363,1455,1.0407635517,0.4703245624,2.3030665565,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,552,1438,0.703576793,0.3818577506,1.2963474039,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,1.6081671766,0.509009544,5.0808510339,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0483189704,0.6301047828,1.7441109697,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,1.1328645364,0.624757251,2.054209144,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,0.5113046049,0.1071639573,2.4395552914,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,1.1652867124,0.5207725021,2.6074593351,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,0.8510270395,0.4575319424,1.5829430798,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,1.4779536467,0.4629927758,4.7178856694,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9858699922,0.5917677965,1.6424341565,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,1.140357452,0.6279212032,2.0709845626,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,0.5114364743,0.1069151708,2.4464934707,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3363,1455,1.1139273109,0.5023068184,2.470271174,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,552,1438,0.8079666373,0.4295063737,1.5199077988,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1493,1.7433555401,0.5496910867,5.5290846305,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.054914958,0.6363216282,1.7488727701,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,552,7253,1.3315793949,0.709458241,2.4992361529,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,0.4820097292,0.1009845958,2.3006813779,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3363,1455,1.0412334788,0.470543508,2.3040742016,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,552,1438,0.6985044504,0.3836688619,1.2716915956,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,1.6081813043,0.5090603456,5.0804332535,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0490459059,0.6306196785,1.7451046173,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.1404412086,0.6222806065,2.0900637697,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,0.5299951448,0.1106709345,2.5381086249,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3363,1455,1.2359795712,0.5496457079,2.7793276258,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,552,1438,0.9078845228,0.4945980404,1.6665134907,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,1.623328409,0.5021977086,5.2473260599,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3363,5236,0.9992023115,0.6018755783,1.6588233438,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,1.325519105,0.7000504247,2.5098204868,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,0.4779813153,0.1008123515,2.2662514508,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3363,1455,1.1084857606,0.4982779082,2.4659746319,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1438,0.8067404846,0.4224507039,1.5406062849,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,1.530900811,0.469121014,4.9958480293,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3363,5236,1.0344863576,0.6058635613,1.7663416196,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,1.2867022923,0.7140467161,2.3186197089,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,678,343,1.6791318797,0.367511174,7.671831685,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3222,1426,1.5484089147,0.7609946667,3.150574205,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,525,1412,1.7827906515,0.7223266906,4.4001454586,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,678,1478,1.1619478361,0.5445466331,2.4793519814,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.8496825398,0.5999676818,1.2033321802,1,0
Inflammatory bowel disease,Crohns Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,525,7206,1.7985361738,0.9058937193,3.5707636553,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,678,343,3.7846596687,0.618477136,23.159544588,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3222,1426,1.6715071504,0.7901532555,3.5359420901,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,525,1412,2.7089589777,0.8750537546,8.3862947896,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,678,1478,2.136670151,0.5985731684,7.6270697977,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.7521651395,0.5062183516,1.1176054668,1,0
Inflammatory bowel disease,Crohns Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,525,7206,2.544428959,1.0399065343,6.2256736681,1,1
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,678,343,3.5696778795,0.5897796709,21.605695807,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3222,1426,1.5532305434,0.7336695666,3.2882992981,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,525,1412,2.5118911353,0.8694818601,7.2567322739,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,678,1478,2.3165438195,0.6283572509,8.5403252047,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.778000526,0.5217754878,1.1600483973,1,0
Inflammatory bowel disease,Crohns Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,525,7206,2.5735286286,1.0379521146,6.3808816503,1,1
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,678,343,3.7709321286,0.6198231599,22.941913177,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3222,1426,1.6565090167,0.7750120405,3.5406186988,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,525,1412,2.669268247,0.8277964254,8.6071801667,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,678,1478,2.1250438636,0.6033024339,7.4851536623,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.7512386371,0.5049528893,1.1176478081,1,0
Inflammatory bowel disease,Crohns Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,525,7206,2.498667339,0.9638624944,6.4774161326,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,678,343,3.7783280946,0.6172661146,23.127404621,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3222,1426,1.6733460496,0.791162489,3.5392059666,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,525,1412,2.5977076773,0.8424310596,8.010252115,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,678,1478,2.1377395191,0.5987964072,7.6318598381,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.7561876644,0.5089624081,1.1235010183,1,0
Inflammatory bowel disease,Crohns Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,525,7206,2.6621876905,1.0855861371,6.5284946604,1,1
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,678,343,3.5522615969,0.591663354,21.327267215,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3222,1426,1.5523040108,0.7281876543,3.3091027123,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,525,1412,2.4155182761,0.7921345495,7.3658301436,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,678,1478,2.3052077378,0.6354542208,8.3624949536,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.7810017019,0.5222353561,1.1679861414,1,0
Inflammatory bowel disease,Crohns Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,525,7206,2.6787599249,0.9909308203,7.2414285519,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,678,343,3.4234358292,0.5832648482,20.093638273,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3222,1426,1.4691997482,0.6917231458,3.1205373326,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,525,1412,2.3940322182,0.806573124,7.1058532591,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,678,1478,2.3281211088,0.6222088495,8.7111391963,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3222,5173,0.7635997133,0.5151230662,1.1319324649,1,0
Inflammatory bowel disease,Crohns Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,525,7206,2.6220510891,1.063427154,6.4650896749,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,703,348,1.2961698941,0.1451531073,11.574374302,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3284,1436,0.8698831871,0.4634301449,1.632817303,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,529,1401,1.9251295666,0.8353497753,4.4366132099,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,703,1487,0.4748949612,0.1616295191,1.3953220022,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.8013670714,0.5568189483,1.1533177617,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,529,7216,1.6535916178,0.8939462216,3.0587580913,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,703,348,1.1041681478,0.1188747388,10.256067111,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3284,1436,0.7161606779,0.3466870285,1.4793922888,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,529,1401,1.7832096889,0.6720778355,4.7313519751,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,703,1487,0.4061065856,0.1266145027,1.3025566208,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7586069384,0.486580083,1.182712789,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,529,7216,1.5419051152,0.7079060576,3.3584560532,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,703,348,1.0868584269,0.1164889678,10.140541738,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3284,1436,0.7391644002,0.3552984088,1.537760927,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,529,1401,1.9133979758,0.7464555864,4.9046344895,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,703,1487,0.3889379646,0.1193178642,1.267813008,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7416369396,0.4735322222,1.161537324,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,529,7216,1.5249509487,0.6957145253,3.3425712867,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,703,348,1.1093834361,0.119527894,10.296605812,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3284,1436,0.7217494881,0.3475020338,1.499048273,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,529,1401,1.8042594128,0.6844800998,4.7559483902,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,703,1487,0.4091781044,0.1274298115,1.3138740392,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7593179268,0.4866944784,1.1846522605,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,529,7216,1.5639167678,0.722086376,3.3871787894,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,703,348,1.10381919,0.1188342192,10.253080403,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3284,1436,0.7163175344,0.3468038126,1.4795420105,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,529,1401,1.7621592902,0.6720399582,4.620566569,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,703,1487,0.4062022858,0.1266495382,1.3028100954,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7598126686,0.4876896849,1.1837758912,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,529,7216,1.5660985939,0.7054737731,3.4766208173,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,703,348,1.0904111037,0.1169201141,10.169305635,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3284,1436,0.744745147,0.3556854889,1.5593701496,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,529,1401,1.9038551704,0.7516352033,4.8223719351,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,703,1487,0.3922170703,0.120297746,1.2787789906,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7443338134,0.4754126309,1.1653725411,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,529,7216,1.5688781397,0.7070459214,3.4812146463,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,703,348,1.1387325518,0.1226642999,10.571224277,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3284,1436,0.7580503447,0.3659922605,1.5700887346,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,529,1401,1.9274163834,0.7376282529,5.0363227011,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,703,1487,0.3909009086,0.1183691516,1.2909066108,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3284,5198,0.7498933731,0.4785766181,1.1750262125,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,529,7216,1.4593289297,0.6594971289,3.2291890773,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,716,349,6283647.3634,1532021.4336,25772631.715,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,1919779.679,604686.62362,6094981.8829,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,552,1433,3001571.2511,431642.64801,20872427.73,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,716,1492,4.4518047933,0.4112629377,48.189525727,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,1.0040623485,0.2291452161,4.3995734087,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7250,1.8111377319,0.2291973993,14.311767472,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,716,349,1740310.0526,361266.97262,8383492.842,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,701630.78117,179100.64269,2748654.308,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,552,1433,275292.59566,40180.953108,1886117.8584,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,716,1492,3.8695889363,0.3314994864,45.169658329,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9255449561,0.1805649376,4.7441849849,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7250,0.4205463064,0.0515500119,3.4308274491,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,716,349,4164284.2639,906239.05959,19135418.24,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,1363807.4505,363912.72045,5111035.305,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1433,387868.95185,51486.506306,2921975.7682,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,716,1492,4.1818307012,0.3451998661,50.659660472,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9153568242,0.1718179068,4.8765471029,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7250,0.4152204876,0.0515107569,3.3470300884,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,716,349,1698939.2057,349772.45361,8252206.2409,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3362,1455,655249.47057,172376.8281,2490774.8531,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,552,1433,245501.62274,32405.521137,1859900.5556,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,716,1492,3.7029033587,0.3205053375,42.780857857,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9200372824,0.1794717657,4.7164443803,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,552,7250,0.3651252398,0.0398520733,3.3452824333,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,716,349,1813301.554,372303.07252,8831682.4876,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3362,1455,708510.85701,179918.64485,2790081.2332,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,552,1433,251211.2525,38306.699639,1647416.6132,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,716,1492,3.8625050867,0.330982637,45.074707489,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9089533559,0.1771346849,4.6642260016,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7250,0.3583752627,0.0363454486,3.5336702059,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,716,349,14461738.603,3116337.3002,67111439.9,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3362,1455,3302370.7506,880274.53785,12388921.985,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,552,1433,738217.83895,109993.0013,4954547.7558,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,716,1492,3.9098071921,0.3297609972,46.356580703,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.8776956385,0.1643893448,4.6861287429,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7250,0.3229209227,0.0331433216,3.1462725304,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,716,349,4078213.2218,897174.60823,18538000.218,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,2044632.7186,547938.80502,7629543.5104,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1433,565212.95807,73097.694244,4370393.5024,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,716,1492,4.4868136884,0.3744579848,53.761697957,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9033926139,0.1693808747,4.818243004,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7250,0.3585825505,0.0461500257,2.786161947,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,718,350,13315773.173,3057030.6502,58000666.493,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,1858433.8547,241131.79161,14323189.693,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,552,1435,6300444.8661,875428.59007,45344195.93,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,11329678.349,2794209.0661,45938442.136,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,1.3368319731,0.0827069732,21.607848226,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,2.400294862,0.2932100526,19.649447124,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,1518435.3789,342684.45519,6728189.6363,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,59775.933587,8330.5185251,428924.34912,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,552,1435,3622168.8071,525451.52089,24969205.237,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,1516178.151,349566.19212,6576139.9058,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.6480440807,0.0404328138,10.386641223,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,552,7253,9.4790459946,1.2688580339,70.813527255,1,1
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,3381605.047,725844.42157,15754412.866,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,127012.73592,17623.030256,915406.42287,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1435,6964262.8494,1141267.493,42497448.962,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,5492904.877,1273631.0527,23689752.165,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.6957723345,0.0433728207,11.161347907,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,9.8984896918,1.2961320048,75.594227916,1,1
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,1494552.8704,326944.0598,6832019.7765,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3362,1455,65074.0839,9119.0537508,464372.34731,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,552,1435,4115001.3584,553999.72016,30565423.706,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1493,1531057.5884,348234.7882,6731485.2464,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.655726336,0.0409509685,10.499801179,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,552,7253,10.822654798,1.3232199477,88.518811311,1,1
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,4735838.1298,1068291.6177,20994419.894,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3362,1455,183476.47094,25565.418518,1316763.7121,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,552,1435,9552097.0131,1382072.944,66018626.399,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,4852439.9184,1118675.4469,21048261.342,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.6516310702,0.040646911,10.446625384,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,10.036340195,1.3444026195,74.924076352,1,1
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,4180293.7332,941160.02224,18567358.667,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3362,1455,152896.74051,21317.536451,1096628.2765,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,552,1435,8229261.8794,1136200.4342,59602820.981,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,7320615.6277,1738813.423,30820680.62,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.7175507893,0.0448029656,11.492077116,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,552,7253,13.6358033,1.5166018811,122.59982923,1,1
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,6183151.3618,1201371.5947,31823093.646,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,285231.85439,38617.668274,2106735.4503,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,552,1435,7681234.4031,1366005.1253,43192635.857,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,8276228.5915,1873237.657,36565547.058,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.7152794784,0.0445063667,11.495540299,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,552,7253,10.106298618,1.3508789946,75.608009431,1,1
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,718,350,1.0420634056,0.8650844625,1.2552486935,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,323568.63213,44911.005923,2331202.7319,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,546,1426,0.8899216453,0.2211488415,3.58111998,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,0.9557004538,0.8461002527,1.0794977954,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.3413970271,0.038211138,3.0502082985,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,546,7242,1.7296608613,0.5282886384,5.6630532585,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,1.0291226247,0.7051240128,1.5019959006,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3362,1455,600813.65975,79666.646677,4531093.8617,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,546,1426,1.0652551882,0.223741752,5.0717785393,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1493,0.9980339332,0.7681677221,1.2966852201,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9452839514,0.1051130206,8.5009615712,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,546,7242,1.8342291913,0.4898200854,6.868637744,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,1.1854405073,0.83388163,1.6852142388,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,746857.86145,104673.47955,5328920.6359,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,546,1426,1.3918577395,0.2631980992,7.3604937603,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,0.7858178508,0.5042041042,1.224721674,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.8356790274,0.0879099193,7.9440345579,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,546,7242,1.7689378818,0.4823285476,6.4875721024,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,1.0744705434,0.758824874,1.5214142131,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3362,1455,641180.78987,84833.6786,4846103.7183,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,546,1426,1.1671392235,0.2339471597,5.8227420614,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1493,1.0595359688,0.7862310884,1.4278454334,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9525848045,0.1058286674,8.5744045741,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,546,7242,2.0506346408,0.5057159963,8.3151461709,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,1.0291177705,0.7043805761,1.5035669943,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3362,1455,600932.02557,79671.374733,4532610.3705,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,546,1426,1.066077189,0.2282746085,4.9787428421,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,0.9980051603,0.7680843236,1.2967512411,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.9451244864,0.1050985466,8.4992640085,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,546,7242,1.8308936292,0.4629438786,7.2409888886,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,1.1767283199,0.7989974673,1.7330337023,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3362,1455,811818.09855,112388.79718,5864006.3929,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,546,1426,1.4328169905,0.2791718579,7.3537660425,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1493,0.8200010405,0.5255086869,1.2795253876,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.8463864109,0.0889368101,8.054819544,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,546,7242,1.8926229517,0.4845317086,7.392749687,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,1.1021055818,0.7929501392,1.5317945651,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3362,1455,1469827.7834,213738.8104,10107634.214,0,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,546,1426,1.3499878406,0.2439789489,7.4697722,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1493,0.824195645,0.5004643609,1.3573363347,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3362,5236,0.8511301582,0.0834523663,8.6806711199,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,546,7242,1.6456963353,0.4382846354,6.1793551702,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,712,350,18176.556685,2560.686919,129022.88463,0,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3345,1445,2.6866551472,0.6297598978,11.461695012,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,530,1380,0.797884645,0.4170135778,1.5266167355,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1491,0.1415791489,0.0187975861,1.0663419936,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6520406205,0.3880125532,1.0957299377,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,530,7191,0.8906598093,0.5103172071,1.5544741288,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,712,350,82325.492154,13553.080018,500069.84755,0,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3345,1445,2.4668121717,0.57273713,10.624703677,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,530,1380,0.451249256,0.218333045,0.9326389005,1,1
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1491,1.4330623794,0.1972404209,10.41200264,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6477803769,0.3740739749,1.121755174,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,530,7191,0.5717532033,0.3047570666,1.0726633156,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,350,85535.535625,14416.456542,507498.34629,0,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3345,1445,2.5619896823,0.5925786342,11.076658444,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,530,1380,0.4703558932,0.2234568936,0.9900552304,1,1
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1491,1.3595547287,0.1773387106,10.422930528,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.63583924,0.3657967622,1.1052354227,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,530,7191,0.5688242759,0.3033224868,1.0667229464,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,712,350,80959.378505,13670.885541,479443.77475,0,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3345,1445,2.409682507,0.5588150623,10.390861264,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,530,1380,0.4309701114,0.2093032973,0.8873975677,1,1
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,712,1491,1.4033997182,0.1986043749,9.9168549005,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6464777017,0.3732927412,1.1195862461,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,530,7191,0.5424477025,0.2933461417,1.0030795298,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,712,350,82334.81017,13554.093235,500145.66437,0,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3345,1445,2.4673528475,0.5728587129,10.627105667,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,530,1380,0.4479199983,0.2192152881,0.9152296206,1,1
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1491,1.4331274443,0.1972459912,10.412654062,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6480416152,0.3742435609,1.1221513979,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,530,7191,0.5738036383,0.3042383441,1.0822127512,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,712,350,84664.285702,14521.400241,493619.15205,0,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3345,1445,2.5117717956,0.5802797013,10.872338872,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,530,1380,0.4486100907,0.2151812419,0.9352628121,1,1
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1491,1.3279067431,0.1787490286,9.8648721719,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6334149026,0.3643837155,1.1010767546,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,530,7191,0.5404227822,0.2912615719,1.0027302319,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,350,100495.81921,22540.312977,448059.86894,0,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3345,1445,2.1166630611,0.4793293052,9.3469405388,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,530,1380,0.4133127838,0.1880981296,0.9081826471,1,1
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1491,1.4145179266,0.1880300236,10.641178076,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3345,5223,0.6952921357,0.3919509281,1.2333971404,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,530,7191,0.6934749029,0.3637295449,1.322156662,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,718,350,1.0199864164,0.7074405691,1.4706144023,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3360,1453,2448914.2233,538435.78492,11138154.337,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,551,1436,0.3169402188,0.0334934228,2.9991291989,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,718,1492,7.8330912E-7,1.8917818E-7,3.2433612E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3360,5232,2.84873849,0.5119584868,15.851502015,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,551,7250,0.3483415907,0.0526956424,2.3026925635,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,1.2760574739,0.9040542481,1.8011338147,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3360,1453,3163784.6972,782845.21222,12786095.455,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,551,1436,0.3709373464,0.0285982866,4.8112852667,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1492,5.739718E-7,1.3720373E-7,2.4011273E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3360,5232,2.8195016485,0.4831572362,16.45342127,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,551,7250,0.3429826578,0.054176133,2.1713824356,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,718,350,1.0026863368,0.7059301176,1.4241918075,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3360,1453,2370201.6449,554405.45817,10133117.837,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,551,1436,0.2980711849,0.0291064136,3.0524692094,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,718,1492,7.6538272E-7,1.8597447E-7,3.1499523E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3360,5232,2.8372020612,0.5140790011,15.658518476,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,551,7250,0.3246434812,0.0440926464,2.3902713614,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,718,350,0.9146084028,0.6488974348,1.2891228806,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3360,1453,3204551.9036,697017.19257,14732997.999,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,551,1436,0.3563612126,0.0341357061,3.7202486293,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1492,4.2359638E-7,1.0316346E-7,1.7393164E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3360,5232,2.776087878,0.4911665009,15.690532421,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,551,7250,0.2881999722,0.0558588522,1.486948276,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,718,350,1.2289617334,0.8325813352,1.8140533282,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3360,1453,3275979.081,821775.69658,13059572.075,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,551,1436,0.4421415193,0.0228432716,8.5578426017,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,718,1492,5.0479279E-7,1.2092067E-7,2.107297E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3360,5232,2.7318122033,0.4618093906,16.159909406,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,551,7250,0.2761280804,0.0473063075,1.6117663984,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,718,350,0.7312544701,0.4971893346,1.0755120089,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3360,1453,4135087.9331,1017392.7497,16806638.558,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,551,1436,0.3412695998,0.0261998108,4.4452588092,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,718,1492,2.539476E-7,6.0979221E-8,1.0575633E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3360,5232,3.0157439248,0.5101127706,17.8288252,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,551,7250,0.3413489575,0.0529863808,2.1990388681,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,714,348,1.487925721,0.173281018,12.7764886,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3356,1453,1.6859575024,0.3844111596,7.3943032846,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,536,1370,1.4584938041,0.7908172284,2.6898809235,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,714,1492,0.4978791986,0.1888582069,1.3125386528,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.4299851811,0.2359098055,0.7837200983,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,536,7157,0.8449801931,0.5317227133,1.3427892186,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,714,348,1.3063392583,0.1388345076,12.291773039,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3356,1453,2.8646093219,0.6124664473,13.398263045,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,536,1370,1.6347732858,0.7875479311,3.3934235498,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,714,1492,0.3487506308,0.1105382954,1.1003155252,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.6421824575,0.3018763669,1.3661165761,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,536,7157,0.9032520005,0.4897070122,1.6660251048,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,714,348,1.3250838597,0.1400807672,12.53453468,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3356,1453,2.929894501,0.6218199147,13.805093056,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,536,1370,1.7359954921,0.8599904678,3.5043183167,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,714,1492,0.340091467,0.1077854265,1.0730783337,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.6343812149,0.2997179879,1.3427273039,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,536,7157,0.8959127774,0.4816358474,1.6665281643,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,714,348,1.3383936238,0.1424742241,12.572782929,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3356,1453,2.9809853588,0.6354437532,13.98435922,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,536,1370,1.7624412798,0.8387492884,3.7033703725,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,714,1492,0.3614362873,0.1149453149,1.136507302,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.6462054255,0.3037150319,1.374912033,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,536,7157,0.9862917431,0.528536951,1.8404983809,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,714,348,1.3051892489,0.138655119,12.286015744,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3356,1453,2.8612595249,0.6112929797,13.392606067,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,536,1370,1.672557331,0.803997963,3.4794217827,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,714,1492,0.3487337102,0.1105027533,1.1005626291,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.6403044451,0.3009406402,1.3623609698,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,536,7157,0.8788602717,0.4705779447,1.6413760693,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,714,348,1.3408856399,0.1420771848,12.654912198,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3356,1453,3.0079271444,0.6366743234,14.210759525,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,536,1370,1.8610886108,0.913360115,3.7922072143,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,714,1492,0.354523137,0.1125808261,1.116412617,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.6390500536,0.3016165119,1.3539874471,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,536,7157,0.951016366,0.4927167287,1.8356026409,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,714,348,1.419403971,0.1475068789,13.658397815,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3356,1453,3.056295846,0.646612924,14.445959788,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,536,1370,1.7903092529,0.8903234832,3.6000479393,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,714,1492,0.3271669056,0.1051705796,1.0177578606,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3356,5230,0.610446272,0.2944512748,1.2655562498,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,536,7157,0.8552393131,0.4518521512,1.6187469303,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,712,347,0.6527107191,0.2008000182,2.1216695429,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3338,1443,0.9371237076,0.4520523981,1.9426970124,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,528,1366,1.3363515825,0.8257590026,2.1626595003,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1486,0.6542432321,0.3121357937,1.3713076661,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3338,5218,0.8758860601,0.5768194338,1.3300113437,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,528,7116,1.0582225302,0.7288444598,1.5364525426,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,712,347,0.2807376578,0.0753396207,1.0461113534,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3338,1443,1.1727728924,0.5262254208,2.6137016627,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,528,1366,1.2797994004,0.7309161674,2.2408678014,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,712,1486,0.4302429689,0.1877248765,0.9860654364,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.0903180786,0.6441188076,1.8456121737,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,528,7116,1.0392449481,0.6556541306,1.6472557891,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,347,0.2895286623,0.0771624109,1.0863689364,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3338,1443,1.2571699778,0.5590286847,2.827182927,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,528,1366,1.3861989194,0.7811611204,2.4598605769,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1486,0.4025264231,0.1751370657,0.925146945,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.051251481,0.6207649696,1.780270683,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,528,7116,1.0233629441,0.6469179708,1.6188632294,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,712,347,0.2840823821,0.0765052126,1.0548666827,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3338,1443,1.197203571,0.5367618821,2.6702648573,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,528,1366,1.3221073282,0.7473846037,2.3387794965,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,712,1486,0.4389885839,0.1920011162,1.0036971692,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.0939090525,0.6462540373,1.851651125,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,528,7116,1.0806053894,0.675485989,1.7286931581,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,712,347,0.280724743,0.0753353708,1.0460741141,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3338,1443,1.1727111319,0.5261952883,2.6135760419,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,528,1366,1.2809994011,0.7322520745,2.240976192,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1486,0.4302402149,0.187720321,0.986076742,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.0902006036,0.6439735347,1.8456307471,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,528,7116,1.0382087194,0.649976982,1.658331564,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,712,347,0.2910131469,0.0777822339,1.0887917131,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3338,1443,1.276093251,0.566754708,2.8732253342,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,528,1366,1.4124297362,0.7934882344,2.5141617393,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,712,1486,0.4107669666,0.1789753367,0.9427528058,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.0553749278,0.6232672701,1.78706037,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,528,7116,1.0508579107,0.6566029479,1.6818418985,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,712,347,0.2824120862,0.0746920756,1.0678051962,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3338,1443,1.2065936566,0.5369635434,2.711298132,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,528,1366,1.3821868255,0.7768592315,2.4591848087,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,712,1486,0.3985158777,0.1717705564,0.9245758304,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3338,5218,1.0176111929,0.6056444208,1.709802822,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,528,7116,0.9998573398,0.6285998576,1.5903832746,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,666,327,149841.93096,76839.156243,292202.63953,0,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3094,1356,1.3783102454,0.7453601674,2.5487532279,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,494,1328,3.1956067917,1.3917680402,7.3373597265,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,666,1461,1.0420371433,0.4744051624,2.2888482127,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.5329485072,1.080604232,2.1746454957,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,494,7113,1.6346871249,0.9625801905,2.7760824738,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,666,327,33423.418725,14165.189228,78864.101372,0,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3094,1356,1.4982285473,0.7535804043,2.9786984468,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,494,1328,2.2116266786,0.8748569106,5.5909629405,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,666,1461,0.6453622989,0.24736472,1.6837182636,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.6807078475,1.1117248328,2.5408975182,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,494,7113,1.0606773975,0.5666724028,1.9853385063,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,666,327,89168.055685,37506.182763,211990.17252,0,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3094,1356,1.4334195288,0.7257677961,2.8310591305,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,494,1328,2.1007113174,0.8453233747,5.220473219,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6955121823,0.2649006496,1.8261080014,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7129516055,1.1276357554,2.6020842181,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,494,7113,1.0755680188,0.5720076045,2.0224321391,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,666,327,33467.535396,14181.76347,78980.017387,0,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3094,1356,1.5039784425,0.7533313947,3.0025977561,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,494,1328,2.2257139841,0.8986807482,5.5123053974,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6475250497,0.2476234147,1.6932513853,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.6815295983,1.1115238592,2.5438426412,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,494,7113,1.0686269415,0.5887483739,1.9396461894,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,666,327,33525.695916,14212.883544,79081.22818,0,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3094,1356,1.496138335,0.7526421355,2.9740959374,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,494,1328,2.1656331472,0.8611805857,5.4459738252,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6455662179,0.2474801386,1.6839967201,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.6847585478,1.1143818631,2.5470724699,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,494,7113,1.087896208,0.5784759043,2.0459247317,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,666,327,89776.093542,37746.478171,213523.15136,0,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3094,1356,1.4417758739,0.7265544439,2.8610624954,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,494,1328,2.0836081683,0.8563906942,5.0694420526,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,666,1461,0.7019364652,0.2666642813,1.8476970328,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7196719918,1.1307423112,2.6153366068,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,494,7113,1.1201123925,0.6122766869,2.0491581645,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,666,327,84830.749107,34871.177442,206366.87723,0,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3094,1356,1.4002879876,0.7084488366,2.7677460208,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,494,1328,2.1644745471,0.8645789996,5.4187645862,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6924645544,0.261050328,1.8368379874,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7115744945,1.1201323554,2.615304554,1,1
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,494,7113,1.1011288468,0.582835803,2.0803195878,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,666,327,1.4149165225,0.4051197814,4.9417205918,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3094,1356,0.7956693661,0.5221642614,1.2124340691,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,494,1328,1.7650052234,0.9151464148,3.4040929279,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,666,1461,1.2374269689,0.6298134477,2.4312365971,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.82241719,1.327604358,2.5016522388,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,494,7113,3.7159785932,2.2064224042,6.2583197481,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,666,327,0.795426975,0.2120726618,2.9834306186,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3094,1356,0.889330744,0.5554735597,1.4238466592,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,494,1328,1.8928473005,0.9314913821,3.8463811599,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,666,1461,0.6913837583,0.3113962531,1.5350586156,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7885254049,1.2363681971,2.587273865,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,494,7113,3.8071958593,2.1286808981,6.8092593514,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,666,327,0.7976345043,0.211155542,3.013043354,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3094,1356,0.9029676665,0.5633597637,1.4473000369,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,494,1328,1.9415116631,0.9599659949,3.9266677756,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6716463483,0.2990849104,1.5082968131,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7774383129,1.2208474684,2.5877818793,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,494,7113,3.7884511838,2.1107738475,6.7995737153,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,666,327,0.7963086898,0.212439344,2.9848874382,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3094,1356,0.8933592031,0.5557923662,1.4359511111,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,494,1328,1.9067924537,0.9442701425,3.8504420482,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,666,1461,0.694110026,0.3122935287,1.5427432334,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7895474674,1.2363835128,2.5901996469,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,494,7113,3.8416371026,2.1640474383,6.8197098487,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,666,327,0.7939454134,0.2117319542,2.9771100069,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3094,1356,0.8877082147,0.5546074255,1.4208714819,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,494,1328,1.8455930297,0.9136863202,3.727990182,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6916366337,0.3115822053,1.5352649314,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7931284148,1.2396408603,2.5937427645,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,494,7113,3.9163188168,2.1833848282,7.0246677895,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,666,327,0.7948915449,0.2104789145,3.0019756126,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3094,1356,0.9060816638,0.5629352174,1.4583986861,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,494,1328,1.9159389254,0.953548223,3.8496448083,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6734479567,0.2996152179,1.5137153364,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7829475487,1.2238332256,2.5974960435,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,494,7113,3.9527497014,2.2116754599,7.0644316877,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,666,327,0.7645094187,0.2029434338,2.8799879856,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3094,1356,0.8723936882,0.5462770801,1.3931954589,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,494,1328,1.9251618319,0.9498807515,3.9018035401,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,666,1461,0.6790713278,0.3027601496,1.5231128297,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3094,5100,1.7724560998,1.214312693,2.5871430347,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,494,7113,3.8179754701,2.1327052365,6.8349514226,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,678,335,1.0050243269,0.4039897291,2.5002464787,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,3175,1400,1.357949408,0.842990125,2.1874830321,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,526,1397,1.7454132154,0.8855187079,3.4403195161,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,678,1461,0.9886937092,0.5783886595,1.6900664192,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.9517108704,0.7428023523,1.2193736032,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,526,7207,2.9965993193,1.7625060592,5.0947952398,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,678,335,0.5102482374,0.1817317631,1.4326238811,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,3175,1400,1.2509253473,0.7532008828,2.0775522973,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,526,1397,1.5462175494,0.6761445285,3.5359137128,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,678,1461,0.4483998849,0.2227284657,0.9027245627,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8494310357,0.6333971584,1.1391479655,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,526,7207,2.7249093216,1.3675884079,5.4293607404,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,678,335,0.5384132868,0.192587835,1.5052293797,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3175,1400,1.3136299354,0.7919951813,2.1788309422,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,526,1397,1.659814234,0.7139754432,3.8586527277,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,678,1461,0.4230719412,0.2084209763,0.8587900826,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8257089403,0.610597255,1.1166038639,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,526,7207,2.7113469421,1.3646339232,5.38708742,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,678,335,0.4999159243,0.177221126,1.4101926615,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,3175,1400,1.2015031673,0.7219872717,1.9994948907,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,526,1397,1.4436067408,0.6404418478,3.2540041372,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,678,1461,0.4320525623,0.2125034607,0.8784300076,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8444701887,0.6295390053,1.1327811202,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,526,7207,2.521440404,1.2888130013,4.9329590131,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,678,335,0.5095825497,0.1815549971,1.4302794144,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,3175,1400,1.2515924693,0.7536659772,2.0784853724,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,526,1397,1.4848736586,0.6507975179,3.3879197773,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,678,1461,0.4488032917,0.2230007505,0.9032453667,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8543637689,0.637115865,1.1456902735,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,526,7207,2.9022725218,1.4532461506,5.7961177377,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,678,335,0.5403565854,0.1927524756,1.5148196589,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,3175,1400,1.275231226,0.7671313752,2.1198646442,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,526,1397,1.5012043114,0.6553895223,3.4385877529,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,678,1461,0.4056656912,0.1988371946,0.827635158,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8210916995,0.6066386279,1.1113561648,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,526,7207,2.6606476898,1.3654331228,5.1844693168,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,678,335,0.512856598,0.1835898474,1.4326603237,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,3175,1400,1.2685781784,0.7693462476,2.0917637538,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,526,1397,1.5919097194,0.6842810676,3.7034146853,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,678,1461,0.4363763794,0.2137323413,0.890947731,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,3175,5123,0.8450314602,0.6260957555,1.1405254907,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,526,7207,2.7584508214,1.3774804799,5.5238902073,1,1
